Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. German LopezInsider | 200,00 | 746,87 | Acquisition Under Employee Benefit Plan | 3,73 | 15,54k | 1,30% |
| 2026-06-15 | Mr. German LopezInsider | 794,00 | 5,32k | Acquisition Under Employee Benefit Plan | 6,70 | 15,54k | 5,38% |
| 2026-06-15 | Mr. Henrique DiasGlobal VP of Marketing | 140,00 | 522,81 | Acquisition Under Employee Benefit Plan | 3,73 | 12,27k | 1,15% |
| 2026-06-15 | Mr. Arvind UtchanahCFO | 991,00 | 5,76k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 109,66k | 0,91% |
| 2026-06-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,24k | 7,21k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 45,60k | 2,79% |
| 2026-06-15 | Ms. Amal KhouriChief Business Officer | 1,37k | 7,40k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 200,18k | 0,69% |
| 2026-06-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 985,00 | 5,80k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 21,84M | 0,00% |
| 2026-06-15 | Ms. Samira SakhiaPresident, CEO & Director | 2,65k | 15,64k | Acquisition Under Employee Benefit Plan | 3,73 - 6,70 | 448,85k | 0,59% |
| 2026-06-10 | Ms. Melanie GroleauGlobal VP of Medical & Clinical | -34,53k | 40,30k | Derivative Exercise and Sale | 5,04 - 6,64 | 10,39k | - |
| 2026-06-10 | Ms. Melanie GroleauGlobal VP of Medical & Clinical | -14,18k | 32,79k | Derivative Exercise and Sale | 4,11 - 6,64 | 10,39k | - |
| 2026-05-14 | Mr. Robert N. LandeIndependent Director | -40,00k | 244,52k | Verkauf | 6,11 - 6,12 | 203,18k | -16,45% |
| 2026-04-13 | Mr. James Charles GaleIndependent Lead Director | 591,00 | 3,16k | Derivative Exercise and Retained Stock | 5,35 | 53,00k | 1,13% |
| 2026-04-10 | Mr. Michael J. TremblayIndependent Director | -20,00k | 2,75k | Derivative Exercise and Sale | 5,34 - 5,48 | 2,00k | - |
| 2026-04-06 | Mr. Robert N. LandeIndependent Director | -20,00k | 3,74k | Derivative Exercise and Sale | 5,31 - 5,50 | 243,18k | - |
| 2026-03-23 | Mr. Henrique DiasGlobal VP of Marketing | -7,73k | 36,84k | Verkauf | 4,76 | 12,13k | -38,93% |
| 2026-03-26 | Cristiane Zanqueta Coelho PeevInsider | -9,88k | 50,57k | Verkauf | 5,12 | 9,72k | -50,39% |
| 2026-03-23 | Mr. Henrique DiasGlobal VP of Marketing | -3,82k | 2,28k | Derivative Exercise and Sale | 4,17 - 4,76 | 12,13k | - |
| 2026-03-23 | Cristiane Zanqueta Coelho PeevInsider | 7,67k | 35,80k | Derivative Exercise and Retained Stock | 4,67 | 14,66k | 109,64% |
| 2026-03-23 | Luz Tatiana Urrea FrancoInsider | 8,77k | 40,94k | Derivative Exercise and Retained Stock | 4,67 | 8,77k | - |
| 2026-03-23 | Mr. German LopezInsider | 7,52k | 35,12k | Derivative Exercise and Retained Stock | 4,67 | 14,55k | 107,06% |
| 2026-03-23 | Ms. Melanie GroleauGlobal VP of Medical & Clinical | 4,59k | 21,42k | Derivative Exercise and Retained Stock | 4,67 | 10,39k | 79,03% |
| 2026-03-23 | Mr. Henrique DiasGlobal VP of Marketing | 6,58k | 30,71k | Derivative Exercise and Retained Stock | 4,67 | 12,13k | 118,38% |
| 2026-03-23 | Ms. Susan Caroline EmblemGlobal VP of HR | 9,30k | 43,40k | Derivative Exercise and Retained Stock | 4,67 | 44,36k | 26,51% |
| 2026-03-23 | Mônica Barbanti-Cabral-deVasconcellos PercarioInsider | 11,39k | 53,19k | Derivative Exercise and Retained Stock | 4,67 | 21,20k | 116,09% |
| 2026-03-23 | Leopoldo Agustin BosanoInsider | 13,18k | 61,54k | Derivative Exercise and Retained Stock | 4,67 | 19,48k | 209,34% |
| 2026-03-23 | Ms. Samira SakhiaPresident, CEO & Director | 95,95k | 447,99k | Derivative Exercise and Retained Stock | 4,67 | 446,20k | 27,39% |
| 2026-03-23 | Ms. Samira SakhiaPresident, CEO & Director | 332,81k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,91M | 21,09% |
| 2026-03-23 | Ms. Amal KhouriChief Business Officer | 20,13k | 94,00k | Derivative Exercise and Retained Stock | 4,67 | 198,81k | 11,27% |
| 2026-03-23 | Ms. Amal KhouriChief Business Officer | 148,01k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 812,95k | 22,26% |
| 2026-03-23 | Mr. Arvind UtchanahCFO | 36,82k | 171,90k | Derivative Exercise and Retained Stock | 4,67 | 108,67k | 51,24% |
| 2026-03-23 | Mr. Arvind UtchanahCFO | 148,01k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 951,39k | 18,42% |
| 2026-03-23 | Mr. Jonathan Ross GoodmanExecutive Chairman | 123,52k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 1,07M | 13,09% |
| 2026-03-23 | Mr. Jonathan Ross GoodmanExecutive Chairman | 44,13k | 206,03k | Derivative Exercise and Retained Stock | 4,67 | 21,84M | 0,20% |
| 2026-03-19 | Ms. Samira SakhiaPresident, CEO & Director | -115,14k | 0,00 | Other Derivative Disposition | - | 1,58M | -6,80% |
| 2026-03-19 | Mr. Jonathan Ross GoodmanExecutive Chairman | -161,25k | 0,00 | Other Derivative Disposition | - | 943,37k | -14,60% |
| 2026-03-19 | Ms. Amal KhouriChief Business Officer | -71,59k | 0,00 | Other Derivative Disposition | - | 664,94k | -9,72% |
| 2026-03-19 | Mr. Arvind UtchanahCFO | -29,39k | 0,00 | Other Derivative Disposition | - | 803,38k | -3,53% |
| 2026-03-15 | Ms. Samira SakhiaPresident, CEO & Director | 3,00k | 13,11k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 350,25k | 0,86% |
| 2026-03-15 | Ms. Amal KhouriChief Business Officer | 1,42k | 6,11k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 178,68k | 0,80% |
| 2026-03-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,42k | 6,17k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 35,07k | 4,21% |
| 2026-03-15 | Cristiane Zanqueta Coelho PeevInsider | 456,00 | 2,05k | Acquisition Under Employee Benefit Plan | 4,49 | 6,99k | 6,97% |
| 2026-03-15 | Mr. Henrique DiasGlobal VP of Marketing | 131,00 | 505,31 | Acquisition Under Employee Benefit Plan | 3,86 | 9,42k | 1,41% |
| 2026-03-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 1,11k | 4,86k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 21,79M | 0,01% |
| 2026-03-15 | Mr. Arvind UtchanahCFO | 1,30k | 5,67k | Acquisition Under Employee Benefit Plan | 3,86 - 4,49 | 71,86k | 1,84% |
| 2026-03-15 | Mr. German LopezInsider | 1,00k | 4,50k | Acquisition Under Employee Benefit Plan | 4,49 | 7,03k | 16,63% |
| 2025-12-15 | Ms. Samira SakhiaPresident, CEO & Director | 3,58k | 15,26k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 347,25k | 1,04% |
| 2025-12-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 1,33k | 5,67k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 21,79M | 0,01% |
| 2025-12-15 | Ms. Amal KhouriChief Business Officer | 1,70k | 7,11k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 177,25k | 0,97% |
| 2025-12-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,69k | 7,19k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 33,65k | 5,29% |
| 2025-12-15 | Mr. Arvind UtchanahCFO | 1,33k | 5,66k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 70,56k | 1,92% |
| 2025-12-15 | Cristiane Zanqueta Coelho PeevInsider | 470,00 | 2,06k | Acquisition Under Employee Benefit Plan | 4,38 | 6,54k | 7,75% |
| 2025-12-15 | Mr. Henrique DiasGlobal VP of Marketing | 631,00 | 2,69k | Acquisition Under Employee Benefit Plan | 3,78 - 4,38 | 9,29k | 7,29% |
| 2025-12-15 | Mr. German LopezInsider | 1,04k | 4,56k | Acquisition Under Employee Benefit Plan | 4,38 | 6,02k | 20,89% |
| 2025-12-10 | Mr. Jonathan Ross GoodmanExecutive Chairman | 3,10k | 13,33k | Kauf | 4,30 | 21,79M | 0,01% |
| 2025-09-15 | Cristiane Zanqueta Coelho PeevInsider | 868,00 | 4,02k | Acquisition Under Employee Benefit Plan | 4,63 | 6,07k | 16,69% |
| 2025-09-15 | Mr. Henrique DiasGlobal VP of Marketing | 612,00 | 2,63k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 8,66k | 7,60% |
| 2025-09-15 | Mr. German LopezInsider | 966,00 | 4,47k | Acquisition Under Employee Benefit Plan | 4,63 | 4,98k | 24,05% |
| 2025-09-15 | Ms. Samira SakhiaPresident, CEO & Director | 3,03k | 13,05k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 343,67k | 0,89% |
| 2025-09-15 | Mr. Jonathan Ross GoodmanExecutive Chairman | 1,12k | 4,84k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 21,79M | 0,01% |
| 2025-09-15 | Ms. Amal KhouriChief Business Officer | 1,48k | 6,08k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 175,56k | 0,85% |
| 2025-09-15 | Ms. Susan Caroline EmblemGlobal VP of HR | 1,44k | 6,15k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 31,96k | 4,71% |
| 2025-09-15 | Mr. Arvind UtchanahCFO | 2,33k | 10,36k | Acquisition Under Employee Benefit Plan | 3,20 - 4,63 | 69,23k | 3,48% |
| 2025-06-02 | Mr. Robert N. LandeIndependent Director | -20,00k | 0,00 | Other Derivative Disposition | - | 60,00k | -25,00% |
| 2025-06-02 | Mr. James Charles GaleIndependent Lead Director | -20,00k | 0,00 | Other Derivative Disposition | - | 70,00k | -22,22% |
| 2025-04-03 | Ms. Samira SakhiaPresident, CEO & Director | -117,50k | 0,00 | Other Derivative Disposition | - | 1,69M | -6,49% |
| 2025-04-03 | Mr. Jonathan Ross GoodmanExecutive Chairman | -182,48k | 0,00 | Other Derivative Disposition | - | 1,10M | -14,18% |
| 2025-04-03 | Ms. Amal KhouriChief Business Officer | -83,97k | 0,00 | Other Derivative Disposition | - | 736,54k | -10,23% |
| 2025-04-03 | Mr. Arvind UtchanahCFO | -27,99k | 0,00 | Other Derivative Disposition | - | 832,77k | -3,25% |
| 2025-03-20 | Mr. Arvind UtchanahCFO | -27,99k | 0,00 | Other Derivative Disposition | - | 672,21k | -4,00% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
